Intravenous (IV) Solutions Market Report

Global and China Intravenous (IV) Solutions Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 05, 2022
  • PAGES：205
  • REPORT CODE：GMM1436107
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Intravenous (IV) Solutions industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Amanta Healthcare (India)

    • Baxter (US)

    • ICU Medical Inc (US)

    • B Braun Melsungen AG (Germany)

    • Grifols SA (Spain)

    • Fresenius Kabi AG (Germany)

    • Terumo Medical Corporation (Tokyo)

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Peripheral Parenteral Nutrition

    • Total Parenteral Nutrition

    Application:

    • Hospital & Clinics

    • Ambulatory

    • Home Care

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Intravenous (IV) Solutions Industry Overview

      • 1.1.1 Intravenous (IV) Solutions Market Scope and Market Segments

      • 1.1.2 Intravenous (IV) Solutions Industry Characteristics

      • 1.1.3 Global and China Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Intravenous (IV) Solutions Production Value and Growth Rate (2017-2028)

    • 1.2 Global Intravenous (IV) Solutions Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Peripheral Parenteral Nutrition

      • 1.2.2 Total Parenteral Nutrition

    • 1.3 Global Intravenous (IV) Solutions Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital & Clinics

      • 1.3.2 Ambulatory

      • 1.3.3 Home Care

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Intravenous (IV) Solutions Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Intravenous (IV) Solutions Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Intravenous (IV) Solutions Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Intravenous (IV) Solutions Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Intravenous (IV) Solutions Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Intravenous (IV) Solutions Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Intravenous (IV) Solutions Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Intravenous (IV) Solutions Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Intravenous (IV) Solutions Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Intravenous (IV) Solutions Industry Porter's Five Forces Model Analysis

      • 2.2.3 Intravenous (IV) Solutions Industry PEST Analysis

    • 2.3 Intravenous (IV) Solutions Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Intravenous (IV) Solutions Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Intravenous (IV) Solutions Industry

    Chapter 3 Global and China Intravenous (IV) Solutions Market, by Manufacturer

    • 3.1 Global and China Intravenous (IV) Solutions Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Intravenous (IV) Solutions Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Intravenous (IV) Solutions Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Intravenous (IV) Solutions Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Intravenous (IV) Solutions Market Top 3 Players

    Chapter 4 Global and China Intravenous (IV) Solutions Market, by Type (2017-2028)

    • 4.1 Intravenous (IV) Solutions Market Trend, by Type

    • 4.2 Global Intravenous (IV) Solutions Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Intravenous (IV) Solutions Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Intravenous (IV) Solutions Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Intravenous (IV) Solutions Price Trend, by Type (2017-2028)

    • 4.3 China Intravenous (IV) Solutions Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Intravenous (IV) Solutions Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Intravenous (IV) Solutions Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Intravenous (IV) Solutions Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Intravenous (IV) Solutions Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Intravenous (IV) Solutions Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Intravenous (IV) Solutions Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Intravenous (IV) Solutions Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Intravenous (IV) Solutions Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Intravenous (IV) Solutions Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Intravenous (IV) Solutions Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Intravenous (IV) Solutions Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Intravenous (IV) Solutions Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Intravenous (IV) Solutions Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Intravenous (IV) Solutions Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Intravenous (IV) Solutions Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Intravenous (IV) Solutions Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Intravenous (IV) Solutions Market Analysis

    • 7.1 North America Intravenous (IV) Solutions Market, by Type

    • 7.2 North America Intravenous (IV) Solutions Market, by Application

    • 7.3 North America Intravenous (IV) Solutions Market Analysis and Forecast, by Country

      • 7.3.1 United States Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Intravenous (IV) Solutions Market Analysis

    • 8.1 Europe Intravenous (IV) Solutions Market, by Type

    • 8.2 Europe Intravenous (IV) Solutions Market, by Application

    • 8.3 Europe Intravenous (IV) Solutions Market Analysis and Forecast, by Country

      • 8.3.1 Germany Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Intravenous (IV) Solutions Market Analysis

    • 9.1 APAC Intravenous (IV) Solutions Market, by Type

    • 9.2 APAC Intravenous (IV) Solutions Market, by Application

    • 9.3 APAC Intravenous (IV) Solutions Market Analysis and Forecast, by Country

      • 9.3.1 China Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Intravenous (IV) Solutions Market Analysis

    • 10.1 Latin America, Middle East and Africa Intravenous (IV) Solutions Market, by Type

    • 10.2 Latin America, Middle East and Africa Intravenous (IV) Solutions Market, by Application

    • 10.3 Latin America, Middle East and Africa Intravenous (IV) Solutions Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Intravenous (IV) Solutions Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Intravenous (IV) Solutions Company Profiles

      • 11.1 Amanta Healthcare (India)

        • 11.1.1 Amanta Healthcare (India) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Amanta Healthcare (India) Intravenous (IV) Solutions Product Profiles, Application and Specification

        • 11.1.3 Amanta Healthcare (India) Intravenous (IV) Solutions Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Baxter (US)

        • 11.2.1 Baxter (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Baxter (US) Intravenous (IV) Solutions Product Profiles, Application and Specification

        • 11.2.3 Baxter (US) Intravenous (IV) Solutions Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 ICU Medical Inc (US)

        • 11.3.1 ICU Medical Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 ICU Medical Inc (US) Intravenous (IV) Solutions Product Profiles, Application and Specification

        • 11.3.3 ICU Medical Inc (US) Intravenous (IV) Solutions Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 B Braun Melsungen AG (Germany)

        • 11.4.1 B Braun Melsungen AG (Germany) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 B Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product Profiles, Application and Specification

        • 11.4.3 B Braun Melsungen AG (Germany) Intravenous (IV) Solutions Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Grifols SA (Spain)

        • 11.5.1 Grifols SA (Spain) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Grifols SA (Spain) Intravenous (IV) Solutions Product Profiles, Application and Specification

        • 11.5.3 Grifols SA (Spain) Intravenous (IV) Solutions Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Fresenius Kabi AG (Germany)

        • 11.6.1 Fresenius Kabi AG (Germany) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product Profiles, Application and Specification

        • 11.6.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Terumo Medical Corporation (Tokyo)

        • 11.7.1 Terumo Medical Corporation (Tokyo) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product Profiles, Application and Specification

        • 11.7.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Intravenous (IV) Solutions Industry Investment Prospect and Risk Assessment

    • 12.1 Intravenous (IV) Solutions Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Intravenous (IV) Solutions Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure China Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure Global Intravenous (IV) Solutions Production Value and Growth Rate (2017-2028)

    • Figure China Intravenous (IV) Solutions Production Value and Growth Rate (2017-2028)

    • Figure Global Intravenous (IV) Solutions Market Size and Growth Rate of Peripheral Parenteral Nutrition (2017-2028)

    • Figure Global Intravenous (IV) Solutions Market Size and Growth Rate of Total Parenteral Nutrition (2017-2028)

    • Figure Global Intravenous (IV) Solutions Market Size and Growth Rate of Hospital & Clinics (2017-2028)

    • Figure Global Intravenous (IV) Solutions Market Size and Growth Rate of Ambulatory (2017-2028)

    • Figure Global Intravenous (IV) Solutions Market Size and Growth Rate of Home Care (2017-2028)

    • Figure North America Intravenous (IV) Solutions Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Intravenous (IV) Solutions Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Intravenous (IV) Solutions Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Intravenous (IV) Solutions Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Intravenous (IV) Solutions Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Intravenous (IV) Solutions Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Intravenous (IV) Solutions Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Intravenous (IV) Solutions Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Intravenous (IV) Solutions Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Intravenous (IV) Solutions Market Share, by Manufacturer in 2021

    • Figure Global and China Intravenous (IV) Solutions Market Share, by Manufacturer in 2022

    • Table Global Intravenous (IV) Solutions Sales Volume, by Type (2017-2028)

    • Table Global Intravenous (IV) Solutions Sales Volume Share, by Type (2017-2028)

    • Figure Global Intravenous (IV) Solutions Sales Volume Share, by Type (2017-2028)

    • Table Global Intravenous (IV) Solutions Sales Value, by Type (2017-2028)

    • Table Global Intravenous (IV) Solutions Sales Value Share, by Type (2017-2028)

    • Figure Global Intravenous (IV) Solutions Price Trend, by Type (2017-2028)

    • Table China Intravenous (IV) Solutions Sales Volume, by Type (2017-2028)

    • Table China Intravenous (IV) Solutions Sales Volume Share, by Type (2017-2028)

    • Figure China Intravenous (IV) Solutions Sales Volume Share, by Type (2017-2028)

    • Table China Intravenous (IV) Solutions Sales Value, by Type (2017-2028)

    • Table China Intravenous (IV) Solutions Sales Value Share, by Type (2017-2028)

    • Figure China Intravenous (IV) Solutions Price Trend, by Type (2017-2028)

    • Table Global Intravenous (IV) Solutions Sales Volume, by Application (2017-2028)

    • Table Global Intravenous (IV) Solutions Sales Volume Share, by Application (2017-2028)

    • Figure Global Intravenous (IV) Solutions Sales Volume Share, by Application (2017-2028)

    • Table Global Intravenous (IV) Solutions Sales Value, by Application (2017-2028)

    • Table Global Intravenous (IV) Solutions Sales Value Share, by Application (2017-2028)

    • Figure Global Intravenous (IV) Solutions Sales Value Share, by Application (2017-2028)

    • Table China Intravenous (IV) Solutions Sales Volume, by Application (2017-2028)

    • Table China Intravenous (IV) Solutions Sales Volume Share, by Application (2017-2028)

    • Figure China Intravenous (IV) Solutions Sales Volume Share, by Application (2017-2028)

    • Table China Intravenous (IV) Solutions Sales Value, by Application (2017-2028)

    • Table China Intravenous (IV) Solutions Sales Value Share, by Application (2017-2028)

    • Figure China Intravenous (IV) Solutions Sales Value Share, by Application (2017-2028)

    • Figure China Intravenous (IV) Solutions Production, Import, Consumption and Export (2017-2022)

    • Figure North America Intravenous (IV) Solutions Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Intravenous (IV) Solutions Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Intravenous (IV) Solutions Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Intravenous (IV) Solutions Production, Import, Consumption and Export (2017-2022)

    • Table North America Intravenous (IV) Solutions Sales Volume, by Type (2017-2028)

    • Table North America Intravenous (IV) Solutions Sales Volume Share, by Type (2017-2028)

    • Figure North America Intravenous (IV) Solutions Sales Volume Share, by Type (2017-2028)

    • Table North America Intravenous (IV) Solutions Sales Volume, by Application (2017-2028)

    • Table North America Intravenous (IV) Solutions Sales Volume Share, by Application (2017-2028)

    • Figure North America Intravenous (IV) Solutions Sales Volume Share, by Application (2017-2028)

    • Figure United States Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure United States Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure Canada Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Table Europe Intravenous (IV) Solutions Sales Volume, by Type (2017-2028)

    • Table Europe Intravenous (IV) Solutions Sales Volume Share, by Type (2017-2028)

    • Figure Europe Intravenous (IV) Solutions Sales Volume Share, by Type (2017-2028)

    • Table Europe Intravenous (IV) Solutions Sales Volume, by Application (2017-2028)

    • Table Europe Intravenous (IV) Solutions Sales Volume Share, by Application (2017-2028)

    • Figure Europe Intravenous (IV) Solutions Sales Volume Share, by Application (2017-2028)

    • Figure Germany Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure UK Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure UK Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure France Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure France Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure Italy Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure Spain Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure Poland Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure Russia Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Table APAC Intravenous (IV) Solutions Sales Volume, by Type (2017-2028)

    • Table APAC Intravenous (IV) Solutions Sales Volume Share, by Type (2017-2028)

    • Figure APAC Intravenous (IV) Solutions Sales Volume Share, by Type (2017-2028)

    • Table APAC Intravenous (IV) Solutions Sales Volume, by Application (2017-2028)

    • Table APAC Intravenous (IV) Solutions Sales Volume Share, by Application (2017-2028)

    • Figure APAC Intravenous (IV) Solutions Sales Volume Share, by Application (2017-2028)

    • Figure China Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure China Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure Japan Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure India Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure India Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Intravenous (IV) Solutions Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Intravenous (IV) Solutions Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Intravenous (IV) Solutions Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Intravenous (IV) Solutions Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Intravenous (IV) Solutions Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Intravenous (IV) Solutions Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Intravenous (IV) Solutions Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Intravenous (IV) Solutions Sales Value and Growth Rate (2017-2028)

    • Table Amanta Healthcare (India) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amanta Healthcare (India) Product Profiles, Application and Specification

    • Table Amanta Healthcare (India) Intravenous (IV) Solutions Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Baxter (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Baxter (US) Product Profiles, Application and Specification

    • Table Baxter (US) Intravenous (IV) Solutions Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table ICU Medical Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table ICU Medical Inc (US) Product Profiles, Application and Specification

    • Table ICU Medical Inc (US) Intravenous (IV) Solutions Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table B Braun Melsungen AG (Germany) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table B Braun Melsungen AG (Germany) Product Profiles, Application and Specification

    • Table B Braun Melsungen AG (Germany) Intravenous (IV) Solutions Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Grifols SA (Spain) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Grifols SA (Spain) Product Profiles, Application and Specification

    • Table Grifols SA (Spain) Intravenous (IV) Solutions Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Fresenius Kabi AG (Germany) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Fresenius Kabi AG (Germany) Product Profiles, Application and Specification

    • Table Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Terumo Medical Corporation (Tokyo) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Terumo Medical Corporation (Tokyo) Product Profiles, Application and Specification

    • Table Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US